|
市場調查報告書
印度生質市場策略分析
Strategic Analysis of Indian Biosimilar Market
|
印度生質市場策略分析 是由出版商Frost & Sullivan在2011年05月所出版的。
這份英文市場調查報告書包含81 Pages 價格從美金6000起跳。
本報告針對印度生質市場動向進行調查分析，提供全球市場與印度市場現況及收益預測、印度規販與研究開發流程概要、印度市場主要企業分析、中國市場概要與主要企業分析，目錄介紹如下。
第1章 摘要整理
第2章 全球生質市場
- 介紹
- 全球人口統計
- 主要生物製藥
- 主要企業製造產品種類
- 市場規模：全球市場
- 市場規模：2011年∼2016年過期專利
- 市場規模：2016年∼2019年過期專利
- 市場規模：主要生物製藥販售
- 市場機會
- 市場規模：收益預測
- 主要企業：全球市場
- 主要企業：動向
第3章 印度生質市場
- 印度市場概要
- 印度市場時間表
- 印度市場檔案
- 印度市場未來性
- 市場成長促進因素（影響順序）
- 對市場有利的一般因素
- 市場成長阻礙因素（影響順序）
- 印度企業面對的困難
- 國内市場未來性：市場觀察動向
- 出口未來性：概要
- 出口未來性：印度企業擴大策略
- 高度限制市場概要：歐洲
- 高度限制市場概要：美國
- 半限制市場概要：中國
- 印度成本優勢
- 印度市場：收益預測
第4章 規範情況
- 生質相關規範
- 國際規範機關：歐盟藥物局（EMA）
- 國際規範機關：US-FDA
第5章 印度市場主要企業
- Biocon
- Dr. Reddy's
- Ranbaxy
- Wockhardt
- Intas Biopharmaceuticals
- Shantha Biotech
第6章 歷史動向與未來影響
- 2001年∼2010年：生質市場歷史觀點
- 2010年∼2015年：市場預測
第7章 中國生質市場
第8章 關於Frost & Sullivan
圖表
Abstract
This research deliverable provides deep insights into the Biosimilar market in
India. It also includes an overview of the Indian regulatory and R&D process
briefing about the biosimilars, trends in regional/local pharmaceutical and
biotechnology development as well as the impact of those developments. The
research deliverable also covers the overview of the other major biosimilar
players like China. The research service also gives a deeper insight into the
profiles of the companies that are into this segment in India. It also covers
the historical trends and future impacts on Biosimilar Markets.
Table of Contents
1. Executive Summary
Brief Summary of Indian Biosimilar Market
- Executive Summary of the Biosimilar market
- Future Impact
2. Global Biosimilar Market
Overview of Global Biosimilar Market
- Introduction to Biosimilars
- Global Population Demographics
- Key Biodrugs
- Types of Products Manufactured by Major Participants
- Market Size of Biosimilars: Global
- Market Size: Biologic Patents Expiring in 2011-2016
- Market Size: Biologics Patents Expiring 2016-2019
- Market Size : Worldwide Sales of Key Biodrugs
- Market Opportunities
- Market Size of Biosimilars: Revenue Forecasts
- Major Participants - Global
- Major Participants - Trends
3. Indian Biosimilar Market
Overview if Indian Biosimilar Market
- Overview of Indian Biosimilar Market
- Timeline of Indian Market
- Indian Market Portfolio
- Domestic Market Potential
- Market Drivers Ranked in Order of Impact
- General Factors favoring the market
- Market Restraints Ranked in Order of Impact
- Hurdles faced by Indian Participants
- Domestic Market Potential - Observed Trends in Market
- Export Potential - Overview
- Export Potential - Expansion Strategy of Indian Participants
- Overview of Highly Regulated Markets: Europe
- Overview of Highly Regulated Markets: The United States
- Overview of Semi-regulated Markets: China
- Cost Advantage of India
- Biosimilar Market in India: Revenue Forecasts
4. Regulatory Scenario
Overview of Regulatory Scenario
- Indian Regulations for Biosimilars
- International Regulatory Authorities European Medicines Agency (EMA)
- International Regulatory Authorities US-FDA
5. Major Participants in Indian Market
Overview of Major Participants in the Indian Market
- Biocon
- Dr. Reddy' s
- Ranbaxy
- Wockhardt
- Intas Biopharmaceuticals
- Shantha Biotech
6. Historical Trends and Future Impact
Overview of Historical trends and Future Impact
- 2001-2010: A Historical View of the Biosimilar Market
- 2010-2015: Frost & Sullivan View on the Biosimilars Market
7. Chinese Biosimilar Market
Overview of Chinese Biosimilar Market
- Overview of Biosimilar Market in China
- China - Major Participants
8. About Frost and Sullivan
Frost and Sullivan: Overview
- Who is Frost and Sullivan
- What makes us unique
- T.E.A.M. Methodology
- Global Perspective
|
